The holy grail of cancer treatment is design a drug that is highly lethal to cancerous tissue but completely spares the normal tissues.
Scientists at Cardiff University have discovered immune cells which could provide such a clever treatment.
It is still early days. The principle has been proven in lab. But to be a useful treatment that can be used in cancer patients, it is still far off.
This particular novel form of immunotherapy using T cells is still in early stages and so many hurdles have to be overcome before this discovery could be employed in cancer treatment.
Nevertheless, it has certainly excited many researchers in the field of cancer and the paper has been published by a premier scientific journal.
Original scientific paper. Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1
Disclaimer: Please note- This blog is NOT medical advice. This blog is purely for information only. See your own doctor to discuss concerns and options relevant for you.